GITNUX MARKETDATA
Browse Our Category
Medical Conditions Disorders
Latest update:
Sti Statistics
Chlamydia, gonorrhea, syphilis and other STIs still hit younger people and marginalized groups hardest, from US chlamydia rates that are 4 times higher for women 15 to 24 than older women to syphilis rates 8 times higher in Black males than White males in 2021. This Sti stats page stitches together the latest 2021 US burden with cross world patterns like Europe’s 2022 gonorrhea surge and the global HIV share among 15 to 19 year old girls, so you can see exactly where prevention has advanced and where it is still lagging.
Lung Cancer Age Statistics
Spot the age patterns that decide outcomes as mean diagnosis centers around 70 years in the US, with the steep global mismatch between 68.5 years (GLOBOCAN 2020) and much earlier disease in places like Nigeria where the median is 58.7 years and 12 percent of cases occur under 50 in India. Then connect why risk and survival swing with age, from US SEER showing 85 percent diagnosed after 60 and lung cancer risk surging after 50, to how 5 year survival can be 28.4 percent under 50 but drops to 4.2 percent at 80 plus in Europe.
Spinal Cord Injury Statistics
Every year about 18,000 new spinal cord injuries are reported in the US, and the pattern is unexpectedly specific: vehicle crashes drive 38 percent of new cases while falls take the lead for people over 65 at 32 percent. From tetraplegia and incomplete injuries to rehab timelines and costs, this page ties the biggest causes to who is affected, how often outcomes are life changing, and what that means for prevention.
Hearing Loss Statistics
Noise and infections are not the only threats. In 2020, hearing loss of some degree affected over 1.5 billion people worldwide and the global bill for unaddressed hearing loss reached US$980 billion, alongside major risk drivers like 22 million US workers exposed to damaging noise each year.
Norovirus Statistics
Supportive care resolves 95% of norovirus cases without sequelae yet the virus can be detected by RT PCR with 95% sensitivity within 72 hours, meaning early timing and rapid tests really matter. From ORS cutting pediatric hospitalizations by 50% to outbreaks where RIDT specificity hits 80% but sensitivity falls to 50%, this page connects the most practical care and testing tradeoffs to the scale of 685 million global cases each year.
Maternal Mortality Rate Statistics
See how maternal death risk still varies by nearly 100 fold between countries, with the global maternal mortality ratio at 223 maternal deaths per 100,000 live births in 2020 and the United States at 23.8 per 100,000 live births in 2021. The page ties those headline gaps to the causes that drive them, from postpartum hemorrhage and hypertensive disorders to access barriers like distant facilities and lack of antenatal care.
Scabies Statistics
Scabies can be deceptive, with intense itching that hits 80 to 90 percent of patients, yet the clues are microscopic, linear grayish-white burrows that can be missed without the right exam. See why symptoms can peak 3 to 4 weeks after exposure and why roughly 1 percent of the US population is affected each year, plus how modern testing like PCR and dermoscopy confirms what skin alone often cannot.
Cancer Survival Statistics
See how survival outcomes can be remarkably similar and sharply different at the same time, with US 5-year cancer survival at 68% overall in 2014–2020 and huge gaps by tumor type and stage, like breast cancer at 91.3% all stages versus pancreatic cancer at 12.5%. You will also find contrasts that stand out for specific groups, including lung cancer at 28.2% for US females versus 24.3% for males and leukemia at 86.3% for children under 20 versus 57.1% for adults.
Metastatic Breast Cancer Statistics
From ER and HER2 status to ESR1, PIK3CA, and TP53 mutations, this up to date metastatic breast cancer statistics page maps the biomarkers that shape outcomes, including a 5 year relative survival of 30.4 percent for distant disease. It also highlights the shift clinicians expect after endocrine therapy, where ctDNA ESR1 mutations predict resistance in 30 percent before progression, alongside how tumor burden and sites of spread drive prognosis and survival from bone to brain.
Breast Cancer Statistics
With an estimated 297,790 new invasive breast cancer cases in the U.S. and breast imaging options that change what gets missed, this page compares how screening tools stack up, from mammography mortality reductions of 20% to 40% to MRI’s higher sensitivity and ultrasound catching cancers mammograms may miss. You will also see how genetics and biomarkers refine risk and treatment, including 85% benign reassurance from palpable masses and molecular tests like Oncotype DX, plus key survival and prevention numbers that explain why the right next step matters.
Tay Sachs Statistics
Tay-Sachs symptoms usually start at 3 to 6 months and the cherry red macular spot appears in up to 90% of infantile cases, yet diagnosis can be confirmed quickly and precisely with HEXA enzyme activity under 5% and high resolution genetic testing. This page also tracks the body’s timeline of change, from hyperacusis that is essentially pathognomonic to seizures in 50 to 70% by age 1, plus the latest risk figures and screening impact that have cut classic infantile Tay-Sachs births by over 90% in Ashkenazi Jewish populations since the 1970s.
Adhd Statistics
From the 2022 U.S. estimate that 14% of children aged 3–17 have been diagnosed with ADHD, this page explains why accurate diagnosis starts with ruling out other disorders and why comorbidities are the rule rather than the exception, including anxiety in 25–50% and learning disabilities in 20–60%. You will also see how timing, symptom overlap, and treatment choices shape outcomes, from the CDC average diagnosis age of 7 years to evidence that rating scales alone fall short and clinical interviews remain essential.
Non Hodgkins Lymphoma Statistics
In 2024, about 80,620 new cases of non Hodgkin lymphoma are expected in the US, and the age adjusted incidence over 2017 to 2021 is 18.6 per 100,000, from there the page switches from global burden to who is most affected, with NHL peaking at 88.7 per 100,000 in ages 75 to 84 and showing a notable male lifetime risk of 2.24% versus 1.60% for females. You will see how the dominant subtype DLBCL and its 5 year relative survival of 64% contrast with indolent forms like follicular lymphoma, alongside risk drivers from immunosuppression and HIV to EBV and H pylori.
Basal Cell Carcinoma Statistics
From 90% arborizing vessels on dermoscopy to 99% cure rates with Mohs, the latest basal cell carcinoma statistics cut through common lookalikes like eczema and scar like plaques to show what actually drives diagnosis and risk. You will also see how common BCC is, why average lesions are 6 to 10 mm yet infiltrative types run larger, and which measurable factors raise recurrence and metastasis concerns.
Pcos Statistics
PCOS is often missed despite being one of the most common reproductive health conditions, with an estimated 1 in 10 women in the United States affected, and as many as 70% undiagnosed globally, so you will see how diagnosis can shift depending on whether Rotterdam or NIH criteria is used. From AMH and HOMA IR to hirsutism scores and exclusion tests, this page turns the lab and ultrasound thresholds into clear proportions, including AMH sensitivity of 92% for polycystic ovaries and insulin resistance in 70% by HOMA IR, helping you understand what actually gets counted.
Bacterial Meningitis Statistics
Fever in 95% and classic meningeal clues like neck stiffness in 80 to 90% and Kernig's sign in 50 to 70% can look straightforward, yet seizures occur in 20 to 30% of adults and up to 40% of children, with sensorineural hearing loss in 10 to 20%, making outcomes depend on spotting patterns fast. From CSF WBC and lactate cutoffs like lactate above 3.0 mmol/L to near universal bacterial detection via Gram stain and rapid PCR, this page helps you connect bedside signs to the tests and current treatment decisions that prevent preventable death and disability.
Women Breast Cancer Statistics
With about 297,790 new invasive breast cancer cases expected for U.S. women in 2023 and lifetime risk reaching about 1 in 8, this page pairs the headline burden with the stark reality that incidence, outcomes, and screening performance vary widely by country and even by subgroup. You will also see how modern detection choices, from mammography to MRI, connect to survival rates like 99.3% for localized disease and why risk factors and prevention options can shift outcomes dramatically.
Cll Relapse Statistics
Relapse is far from uniform in CLL. From a 5 year relapse peak of 34.5% after first line FCR and 18.4% relapse at 48 months in ELEVATE TN with acalabrutinib, the page maps how timing and location shift, with relapse after frontline ibrutinib clustering at a median of 42 months and early nodal driven patterns colliding with rapid MRD led rebounds.
Colorblind Statistics
See how modern colorblind testing can pinpoint your type and severity with precision, from an Anomaloscope matching the Rayleigh equation in 99% of congenital cases to VR screening that speeds up detection by 40% without losing rigor. Then compare real world impact against lab thresholds, with contrast sensitivity dropping 15% in traffic scenarios and genomic sequencing confirming diagnoses in 85% of ambiguous results.
Duchenne Muscular Dystrophy Statistics
From first symptoms at ages 2 to 5 and calf hypertrophy in 80 to 90 percent of boys, to loss of ambulation by a mean age of 12, this page maps the measurable timeline of Duchenne muscular dystrophy with high clinical precision. It also ties the most actionable thresholds to outcomes, including cardiomyopathy in 90 percent by age 18, median survival of 19.5 years without ventilation versus 29.7 with, and how FVC dropping below 40 percent predicted drives ventilatory support, alongside current diagnostic yields like genetic testing detecting mutations in 95 to 98 percent of cases.